Interleukin-1 receptor antagonist - Abbott
Alternative Names: Murine interleukin-1 receptor antagonist protein; Murine IRAP; Recombinant murine interleukin-1 receptor antagonist proteinLatest Information Update: 25 Sep 2021
At a glance
- Originator Abbott Laboratories
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Transplant rejection
Most Recent Events
- 28 Feb 1996 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
- 28 Feb 1996 No-Development-Reported for Transplant rejection in USA (Unknown route)